In this study, we compared the expression level of TIGIT on total NK cells, CD56bright, and CD56dim NK cell subsets in bone marrow between CBF-AML patients at diagnosis and healthy donors (HDs) by performing multi-parameter flow cytometry (MFC) testing. The gene discussed is TIGIT; the disease is acute myeloid leukemia.